Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.01
MDAS's Cash to Debt is ranked lower than
99% of the 1806 Companies
in the Global Health Information Services industry.

( Industry Median: 8.17 vs. MDAS: 0.01 )
Ranked among companies with meaningful Cash to Debt only.
MDAS' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.05 Max: N/A
Current: 0.01
Equity to Asset 0.27
MDAS's Equity to Asset is ranked lower than
86% of the 1719 Companies
in the Global Health Information Services industry.

( Industry Median: 0.61 vs. MDAS: 0.27 )
Ranked among companies with meaningful Equity to Asset only.
MDAS' s Equity to Asset Range Over the Past 10 Years
Min: -0.6  Med: 0.28 Max: 0.61
Current: 0.27
-0.6
0.61
Interest Coverage 0.51
MDAS's Interest Coverage is ranked lower than
98% of the 1173 Companies
in the Global Health Information Services industry.

( Industry Median: 613.26 vs. MDAS: 0.51 )
Ranked among companies with meaningful Interest Coverage only.
MDAS' s Interest Coverage Range Over the Past 10 Years
Min: 0.59  Med: 1.38 Max: 2.79
Current: 0.51
0.59
2.79
F-Score: 5
Z-Score: 1.16
M-Score: -3.04
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 3.18
MDAS's Operating margin (%) is ranked lower than
56% of the 1762 Companies
in the Global Health Information Services industry.

( Industry Median: 4.75 vs. MDAS: 3.18 )
Ranked among companies with meaningful Operating margin (%) only.
MDAS' s Operating margin (%) Range Over the Past 10 Years
Min: -4.99  Med: 13.33 Max: 14.9
Current: 3.18
-4.99
14.9
Net-margin (%) -4.58
MDAS's Net-margin (%) is ranked lower than
71% of the 1763 Companies
in the Global Health Information Services industry.

( Industry Median: 3.38 vs. MDAS: -4.58 )
Ranked among companies with meaningful Net-margin (%) only.
MDAS' s Net-margin (%) Range Over the Past 10 Years
Min: -8.21  Med: 3.61 Max: 16.69
Current: -4.58
-8.21
16.69
ROE (%) -7.66
MDAS's ROE (%) is ranked lower than
74% of the 1707 Companies
in the Global Health Information Services industry.

( Industry Median: 5.90 vs. MDAS: -7.66 )
Ranked among companies with meaningful ROE (%) only.
MDAS' s ROE (%) Range Over the Past 10 Years
Min: -31.53  Med: -2.62 Max: 5.94
Current: -7.66
-31.53
5.94
ROA (%) -2.06
MDAS's ROA (%) is ranked lower than
68% of the 1810 Companies
in the Global Health Information Services industry.

( Industry Median: 3.01 vs. MDAS: -2.06 )
Ranked among companies with meaningful ROA (%) only.
MDAS' s ROA (%) Range Over the Past 10 Years
Min: -2.45  Med: 1.62 Max: 14.99
Current: -2.06
-2.45
14.99
ROC (Joel Greenblatt) (%) 14.71
MDAS's ROC (Joel Greenblatt) (%) is ranked lower than
56% of the 1778 Companies
in the Global Health Information Services industry.

( Industry Median: 22.73 vs. MDAS: 14.71 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MDAS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -27.4  Med: 57.09 Max: 139.34
Current: 14.71
-27.4
139.34
Revenue Growth (3Y)(%) 6.10
MDAS's Revenue Growth (3Y)(%) is ranked higher than
55% of the 1367 Companies
in the Global Health Information Services industry.

( Industry Median: 4.90 vs. MDAS: 6.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MDAS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 6.10 Max: 23.6
Current: 6.1
0
23.6
EBITDA Growth (3Y)(%) -0.40
MDAS's EBITDA Growth (3Y)(%) is ranked lower than
62% of the 1109 Companies
in the Global Health Information Services industry.

( Industry Median: 6.90 vs. MDAS: -0.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MDAS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -0.40 Max: 72.3
Current: -0.4
0
72.3
EPS Growth (3Y)(%) 8.10
MDAS's EPS Growth (3Y)(%) is ranked higher than
54% of the 1027 Companies
in the Global Health Information Services industry.

( Industry Median: 5.80 vs. MDAS: 8.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MDAS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -20.00 Max: 8.1
Current: 8.1
0
8.1
» MDAS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

MDAS Guru Trades in Q1 2015

Mario Gabelli 10,500 sh (-16.00%)
Paul Tudor Jones 21,801 sh (-60.59%)
Joel Greenblatt 16,953 sh (-71.23%)
» More
Q2 2015

MDAS Guru Trades in Q2 2015

Paul Tudor Jones 25,726 sh (+18.00%)
Mario Gabelli 10,500 sh (unchged)
Joel Greenblatt Sold Out
» More
Q3 2015

MDAS Guru Trades in Q3 2015

Joel Greenblatt 289,553 sh (New)
Mario Gabelli 10,500 sh (unchged)
Paul Tudor Jones Sold Out
» More
Q4 2015

MDAS Guru Trades in Q4 2015

Jim Simons 109,348 sh (New)
Mario Gabelli 40,650 sh (+287.14%)
» More
» Details

Insider Trades

Latest Guru Trades with MDAS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 23.20
MDAS's Forward P/E is ranked lower than
65% of the 542 Companies
in the Global Health Information Services industry.

( Industry Median: 17.39 vs. MDAS: 23.20 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 4.20
MDAS's P/B is ranked lower than
71% of the 1662 Companies
in the Global Health Information Services industry.

( Industry Median: 2.30 vs. MDAS: 4.20 )
Ranked among companies with meaningful P/B only.
MDAS' s P/B Range Over the Past 10 Years
Min: 1.26  Med: 2.59 Max: 4.39
Current: 4.2
1.26
4.39
P/S 2.46
MDAS's P/S is ranked lower than
59% of the 1715 Companies
in the Global Health Information Services industry.

( Industry Median: 1.71 vs. MDAS: 2.46 )
Ranked among companies with meaningful P/S only.
MDAS' s P/S Range Over the Past 10 Years
Min: 0.92  Med: 1.88 Max: 4.22
Current: 2.46
0.92
4.22
PFCF 14.86
MDAS's PFCF is ranked higher than
68% of the 764 Companies
in the Global Health Information Services industry.

( Industry Median: 21.65 vs. MDAS: 14.86 )
Ranked among companies with meaningful PFCF only.
MDAS' s PFCF Range Over the Past 10 Years
Min: 5.2  Med: 14.70 Max: 50.8
Current: 14.86
5.2
50.8
POCF 10.11
MDAS's POCF is ranked higher than
69% of the 976 Companies
in the Global Health Information Services industry.

( Industry Median: 15.74 vs. MDAS: 10.11 )
Ranked among companies with meaningful POCF only.
MDAS' s POCF Range Over the Past 10 Years
Min: 3.83  Med: 8.83 Max: 34.86
Current: 10.11
3.83
34.86
EV-to-EBIT 110.23
MDAS's EV-to-EBIT is ranked lower than
93% of the 1152 Companies
in the Global Health Information Services industry.

( Industry Median: 15.01 vs. MDAS: 110.23 )
Ranked among companies with meaningful EV-to-EBIT only.
MDAS' s EV-to-EBIT Range Over the Past 10 Years
Min: -111.5  Med: 28.60 Max: 110.4
Current: 110.23
-111.5
110.4
EV-to-EBITDA 18.72
MDAS's EV-to-EBITDA is ranked lower than
69% of the 1257 Companies
in the Global Health Information Services industry.

( Industry Median: 11.09 vs. MDAS: 18.72 )
Ranked among companies with meaningful EV-to-EBITDA only.
MDAS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.8  Med: 14.00 Max: 59.1
Current: 18.72
8.8
59.1
Shiller P/E 914.77
MDAS's Shiller P/E is ranked lower than
99% of the 285 Companies
in the Global Health Information Services industry.

( Industry Median: 31.77 vs. MDAS: 914.77 )
Ranked among companies with meaningful Shiller P/E only.
MDAS' s Shiller P/E Range Over the Past 10 Years
Min: 204.11  Med: 359.33 Max: 1045
Current: 914.77
204.11
1045
Current Ratio 0.55
MDAS's Current Ratio is ranked lower than
93% of the 1707 Companies
in the Global Health Information Services industry.

( Industry Median: 2.00 vs. MDAS: 0.55 )
Ranked among companies with meaningful Current Ratio only.
MDAS' s Current Ratio Range Over the Past 10 Years
Min: 0.55  Med: 0.70 Max: 2.77
Current: 0.55
0.55
2.77
Quick Ratio 0.55
MDAS's Quick Ratio is ranked lower than
92% of the 1707 Companies
in the Global Health Information Services industry.

( Industry Median: 1.88 vs. MDAS: 0.55 )
Ranked among companies with meaningful Quick Ratio only.
MDAS' s Quick Ratio Range Over the Past 10 Years
Min: 0.55  Med: 0.70 Max: 2.77
Current: 0.55
0.55
2.77
Days Sales Outstanding 57.32
MDAS's Days Sales Outstanding is ranked higher than
62% of the 1432 Companies
in the Global Health Information Services industry.

( Industry Median: 68.31 vs. MDAS: 57.32 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDAS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.01  Med: 64.98 Max: 93.29
Current: 57.32
47.01
93.29
Days Payable 36.59
MDAS's Days Payable is ranked lower than
58% of the 1301 Companies
in the Global Health Information Services industry.

( Industry Median: 44.37 vs. MDAS: 36.59 )
Ranked among companies with meaningful Days Payable only.
MDAS' s Days Payable Range Over the Past 10 Years
Min: 42.44  Med: 61.51 Max: 135.5
Current: 36.59
42.44
135.5

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.30
MDAS's Price/Projected FCF is ranked higher than
58% of the 696 Companies
in the Global Health Information Services industry.

( Industry Median: 1.50 vs. MDAS: 1.30 )
Ranked among companies with meaningful Price/Projected FCF only.
MDAS' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.78  Med: 1.07 Max: 2.38
Current: 1.3
0.78
2.38
Price/Median PS Value 1.31
MDAS's Price/Median PS Value is ranked lower than
68% of the 1359 Companies
in the Global Health Information Services industry.

( Industry Median: 1.01 vs. MDAS: 1.31 )
Ranked among companies with meaningful Price/Median PS Value only.
MDAS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.49  Med: 0.96 Max: 2.07
Current: 1.31
0.49
2.07
Price/Graham Number 2.28
MDAS's Price/Graham Number is ranked lower than
62% of the 1034 Companies
in the Global Health Information Services industry.

( Industry Median: 1.62 vs. MDAS: 2.28 )
Ranked among companies with meaningful Price/Graham Number only.
MDAS' s Price/Graham Number Range Over the Past 10 Years
Min: 0.44  Med: 1.46 Max: 5.12
Current: 2.28
0.44
5.12
Earnings Yield (Greenblatt) (%) 0.90
MDAS's Earnings Yield (Greenblatt) (%) is ranked lower than
61% of the 1751 Companies
in the Global Health Information Services industry.

( Industry Median: 2.90 vs. MDAS: 0.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MDAS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.9  Med: 3.30 Max: 5.1
Current: 0.9
0.9
5.1
Forward Rate of Return (Yacktman) (%) 30.92
MDAS's Forward Rate of Return (Yacktman) (%) is ranked higher than
87% of the 693 Companies
in the Global Health Information Services industry.

( Industry Median: 11.67 vs. MDAS: 30.92 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MDAS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 3.3  Med: 14.30 Max: 34.4
Current: 30.92
3.3
34.4

More Statistics

Revenue(Mil) $764
EPS $ -0.59
Short Percentage of Float2.52%
52-Week Range $17.00 - 31.35
Shares Outstanding(Mil)59.29

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 764 765 794
EPS($) 1.20 1.33 1.35
EPS without NRI($) 1.20 1.33 1.35

Business Description

Industry: Application Software » Health Information Services
Compare: » details
Traded in other countries:58M.Germany,
MedAssets Inc was incorporated in 1999. It is a financial and performance improvement company providing technology-enabled products and services that, together, help mitigate the increasing financial challenges faced by hospitals, health systems, and other non-acute healthcare providers. Its solutions are designed to reduce the total cost of care delivery, enhance operational efficiency, align clinical delivery of physicians and staff to advance care coordination, and improve revenue performance mainly for hospitals and health systems. The Company's solutions integrate with its clients' existing operations and enterprise software systems, and require minimal upfront costs or capital expenditures for its clients. Its technology-enabled solutions are delivered through company-hosted software, sometimes referred to as software as a service or Web-based applications, supported by implementation, process improvement consulting and outsourced services, as well as enterprise-wide sales and client management support. The Company manages its business through two business segments, Spend and Clinical Resource Management (CM) and Revenue Cycle Management (RCM). Within the SCM segment it provides a comprehensive suite of cost management services, supply chain analytics and data capabilities that help its clients reduce their total cost of care delivery, enhance their operational efficiency and align their clinicians' delivery of care with advance care coordination. Its solutions lower operating costs through compliance to its strategic sourcing of supplies and purchased services at discounted prices, supply chain outsourcing and procurement services capabilities. It also help to improve care processes and reduce care variations through the use of its clinical and process improvement consulting services, workforce optimization solutions and business analytics and intelligence tools. The Company's RCM segment is a provider of revenue cycle management solutions to healthcare providers, mainly hospitals and health systems. It provides SaaS or Web-based software and technology-enabled services designed to improve revenue performance for healthcare organizations through patient access and financial responsibility, clinical documentation, charge capture and revenue integrity, pricing analysis, claims processing and denials management, payor contract management, extended business office revenue recovery, accounts receivable services and outsourcing. As of December 31, 2013, the Company's client base included more than 4,400 acute care hospitals and approximately 122,000 ancillary or non-acute provider locations. The Company competes with Allscripts Corporation, Epic Systems Corporation, McKesson Corporation, Siemens AG; Accenture Ltd., Accretive Health, Inc., Deloitte & Touche LLP, Ernst & Young LLP, Craneware Inc., Emdeon Inc. and among others. The Company is subject to federal and state laws and regulations designed to protect patients, government
» More Articles for MDAS

Headlines

Articles On GuruFocus.com
Litespeed Management adds to its stake in MedAssets Jul 07 2015 
Weekly CEO Buys Highlight: APD, MDAS, PNNT, MDU, SRV Feb 23 2015 
Weekly CEO Sells Highlight: Amazon.com Inc, Atmel Corporation, Monolithic Power Systems Inc, MedAsse Nov 10 2013 
Steven Cohen Increases Two High-Growth Positions - OCZ Technology and MedAssets Inc. Apr 17 2012 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 9,000 Shares Mar 08 2011 
MEDASSETS, INC. Reports Operating Results (10-K) Mar 01 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Feb 09 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Jan 05 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Dec 08 2010 
MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 40,000 Shares Dec 01 2010 

More From Other Websites
Leveraged Loans Issuance Fell Last Week Jan 30 2016
MedAssets Named Category Leader in “2015/2016 Best in KLAS” Report Jan 29 2016
MEDASSETS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Jan 27 2016
Pamplona Capital Management Completes Acquisition of MedAssets for $2.75 Billion Jan 27 2016
Pamplona Capital Management Completes Acquisition of MedAssets Jan 27 2016
Pamplona Capital Management Completes Acquisition of MedAssets Jan 27 2016
Pamplona Capital Management Completes Acquisition of MedAssets Jan 27 2016
Pamplona Capital Management Completes Acquisition of MedAssets for $2.75 Billion Jan 27 2016
Citizens Financial Group Set to Join the S&P 500; ZELTIQ Aesthetics, RE/MAX to Join S&P SmallCap 600 Jan 26 2016
Pamplona Capital Management Names CEO, Executive Leadership Team for Combined MedAssets-Precyse... Jan 20 2016
Pamplona Capital Management Names CEO, Executive Leadership Team for Combined MedAssets-Precyse... Jan 20 2016
MedAssets' Shareholders Approve Takeover by Pamplona Jan 15 2016
MEDASSETS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events,... Jan 14 2016
MedAssets' Stockholders Approve Merger With Pamplona Capital Management Jan 14 2016
MedAssets’ Stockholders Approve Merger With Pamplona Capital Management Jan 14 2016
MedAssets, Inc. (New). -- Moody's assigns B3 CFR to MedAssets, Inc. (New); rates LBO financing Jan 06 2016
Two Chinese citizens in insider trading settlement with U.S. regulator Dec 28 2015
MedAssets-Pamplona Deal: HRS Act Waiting Period Over Dec 10 2015
MedAssets and Pamplona Announce Early Termination of HSR Act Waiting Period in Proposed Transaction Dec 09 2015
MEDASSETS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 09 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK